mopidralazine has been researched along with Hypertension, Renal in 2 studies
*Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldoli, E; Bellasio, E; Campi, A; Di Mola, N | 1 |
Baldoli, E; Bianchi, G; Corsico, N; Di Francesco, GF | 1 |
2 other study(ies) available for mopidralazine and Hypertension, Renal
Article | Year |
---|---|
Antihypertensives. N-1H-Pyrrol-1-yl-3-pyridazinamines.
Topics: Animals; Antihypertensive Agents; Dogs; Heart Rate; Hydralazine; Hypertension; Hypertension, Renal; Mutagenicity Tests; Pyridazines; Pyrroles; Rats | 1984 |
Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Avoidance Learning; Dogs; Hemodynamics; Hexobarbital; Hypertension, Renal; Indomethacin; Injections, Intravenous; Male; Pentylenetetrazole; Postural Balance; Pyridazines; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sleep; Species Specificity; Vasodilator Agents | 1985 |